help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamaguchi, H.
Right arrow Articles by Matsukura, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamaguchi, H.
Right arrow Articles by Matsukura, S.
The Journal of Clinical Endocrinology & Metabolism Vol. 82, No. 6 1934-1938
Copyright © 1997 by The Endocrine Society


Experimental Studies

A 5'-Splice Site Mutation in the Cytochrome P450 Steroid 17{alpha}-Hydroxylase Gene in 17{alpha}-Hydroxylase Deficiency

Hideki Yamaguchi, Masamitsu Nakazato, Mikiya Miyazato, Kenji Kangawa and Shigeru Matsukura

Third Department of Internal Medicine, Miyazaki Medical College (H.Y., M.N., M.M., S.M.), Kiyotake, Miyazaki 889–16; and the National Cardiovascular Center Research Institute (M.M., K.K.), Suita, Osaka 565, Japan

Address all correspondence and requests for reprints to: Masamitsu Nakazato, M.D., Ph.D., Third Department of Internal Medicine, Miyazaki Medical College, 5200 Kihara, Kiyotake, Miyazaki 889–16, Japan. E-mail: nakazato{at}post.miyazaki-med.ac.jp

17{alpha}-Hydroxylase deficiency (17OHD) is an autosomal recessive disorder that produces an excess of mineralocorticoids and sexual differentiation abnormalities. Using DNA sequencing analysis of the 17{alpha}-hydroxylase (CYP17) gene from a Japanese patient with 17OHD, we identified a new type of genetic abnormality in this disease, a G to A transition at position +5 in the splice donor site of intron 7 of the CYP17 gene. In vitro expression analysis of an allelic minigene that consists of exons 6–8 of the patient’s CYP17 gene showed that the transition causes the skipping of exon 7. This exon skipping alters the translational reading frame of exon 8 and introduces a premature stop codon (TAA) at amino acid position 410 proximal to the heme iron-binding site essential for the enzymatic activity of CYP17. Restriction enzyme analysis showed that the patient is homozygous for the mutated CYP17 gene, and the parents are heterozygotes. This is the first reported patient with 17OHD caused by the splice site mutation in the CYP17 gene.




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
T. Kubo, S.-R. Kim, K. Sai, Y. Saito, T. Nakajima, K. Matsumoto, H. Saito, K. Shirao, N. Yamamoto, H. Minami, et al.
FUNCTIONAL CHARACTERIZATION OF THREE NATURALLY OCCURRING SINGLE NUCLEOTIDE POLYMORPHISMS IN THE CES2 GENE ENCODING CARBOXYLESTERASE 2 (HCE-2)
Drug Metab. Dispos., October 1, 2005; 33(10): 1482 - 1487.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Costa-Santos, C. E. Kater, E. P. Dias, and R. J. Auchus
Two Intronic Mutations Cause 17-Hydroxylase Deficiency by Disrupting Splice Acceptor Sites: Direct Demonstration of Aberrant Splicing and Absent Enzyme Activity by Expression of the Entire CYP17 Gene in HEK-293 Cells
J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 43 - 48.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. M. Martin, C. J. Lin, E. M. F. Costa, M. L. de Oliveira, A. Carrilho, H. Villar, C. A. Longui, and B. B. Mendonca
P450c17 Deficiency in Brazilian Patients: Biochemical Diagnosis through Progesterone Levels Confirmed by CYP17 Genotyping
J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5739 - 5746.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Di Cerbo, A. Biason-Lauber, M. Savino, M. R. Piemontese, A. Di Giorgio, M. Perona, and A. Savoia
Combined 17{alpha}-Hydroxylase/17,20-Lyase Deficiency Caused by Phe93Cys Mutation in the CYP17 Gene
J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 898 - 905.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Biason-Lauber, B. Kempken, E. Werder, M. G. Forest, S. Einaudi, M. B. Ranke, N. Matsuo, V. Brunelli, E. J. Schönle, and M. Zachmann
17{alpha}-Hydroxylase/17,20-Lyase Deficiency as a Model to Study Enzymatic Activity Regulation: Role of Phosphorylation
J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1226 - 1231.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Suzuki, T. Nagashima, Y. Nomura, K. Onigata, K. Nagashima, and A. Morikawa
A New Compound Heterozygous Mutation (W17X, 436+5G->T) in the Cytochrome P450c17 Gene Causes 17{alpha}-Hydroxylase/17,20-Lyase Deficiency
J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 199 - 202.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society